Abstract
A number of immunomodulatory agents have been under study that facilitate a Th1 immune response, enhancing Tlymphocyte activity and stimulating interferon production. These include cytokines (interleukin [IL]-12, IL-10, IL-2), histamine, oral interferon-like molecules, ribavirin analogues, interferon gamma, thymosin alpha-1, amantadine, inosine-5′-monophosphate dehydrogenase inhibitors, tumor necrosis factor antagonists, and nonspecific hepatoprotectants (glycyrrhizin and caspase inhibitors). The current available data on these drugs are analyzed with an attempt to determine their usefulness as future hepatitis C virus treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
